Send Message
View as an RSS Feed
  • An appeals court ruling yesterday that dismissed the conviction of a sales rep who sold a drug for non-FDA approved uses could have major ramifications for pharmaceutical companies, which have paid billions in fines for doing just that. Two out of three judges agreed with Alfred Caronia that his rights to free speech were violated. The government is expected to appeal the case, which could find its way to the Supreme Court.  [View news story]
    the difference is that the salesman will ALWAYS disclose that it is off label use & not approved by the FDA for a certain indication but.................A politician wont disclose the full story.
    Dec 4, 2012. 11:21 AM | Likes Like |Link to Comment
1 Comment